4basebio PLC (AIM:4BB)
London
· Delayed Price · Currency is GBP · Price in GBX 1,120.00
0.00 (0.00%)
Feb 21, 2025, 8:01 AM GMT+1
4basebio Market Cap
4basebio has a market cap or net worth of 143.42 million as of February 21, 2025. Its market cap has increased by 54.48% in one year.
Market Cap
143.42M
Enterprise Value
156.19M
Revenue
596.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1,120.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 143.42M, an increase of 244.99%. That is a compound annual growth rate of 36.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 143.42M | -7.44% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 58.67B |
| Haleon | 35.36B |
| Smith & Nephew | 8.91B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 5.01B |
| HUTCHMED (China) | 1.98B |
| Oxford Nanopore Technologies | 1.24B |